ReviewTherapeutics and clinical risk management2019

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy.

Chiara Lupi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.